Results 201 to 210 of about 182,326 (341)

Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy

open access: yesBMEMat, EarlyView.
The immunosuppressive tumor microenvironment, characterized by hypoxia, redox imbalance, elevated interstitial fluid pressure, and acidity, was comprehensively elucidated. This review discussed the etiology and consequences of the characteristics of the immunosuppressive tumor microenvironment, and analyzed the recent advancements in nanomaterials for ...
Wen Zhang   +7 more
wiley   +1 more source

3D bioprinting in oral and craniomaxillofacial tissue regeneration: Progress, challenges, and future directions

open access: yesBMEMat, EarlyView.
This paper summarized the application of 3D bioprinting in the regeneration of various tissues in the oral and craniomaxillofacial fields, including the required biomaterials and printing techniques. Abstract Oral and craniomaxillofacial tissues are essential for maintaining oral functions, including respiration, mastication, swallowing, and speech ...
Huilu Zhan   +7 more
wiley   +1 more source

Recent advances in engineered exosome-based therapies for ocular vascular disease. [PDF]

open access: yesJ Nanobiotechnology
Guan J   +5 more
europepmc   +1 more source

Contribution of Monocytes/Macrophages to Compensatory Neovascularization

open access: bronze, 2000
Nicanor I. Moldovan   +4 more
openalex   +1 more source

Honeycomb or Lotus Root‐Like Intracoronary Pattern: Insights From Optical Coherence Tomography of a Recanalized Thrombus

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Spontaneous recanalized coronary thrombus (SRCT) has been identified in autopsy studies as multiple interconnected channels separated by thin septa. Despite its potential clinical significance, SRCT remains underdiagnosed. Recent advances in intracoronary imaging, including optical coherence tomography (OCT), have elucidated its ...
Fernando Quevedo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy